Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification-Reference-Cited by-同舟云学术

Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification

Published:2011-05 Issue:5 Volume:6 Page:942-946
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ou Sai-Hong Ignatius,Kwak Eunice L.,Siwak-Tapp Christina,Dy Joni,Bergethon Kristin,Clark Jeffrey W.,Camidge D. Ross,Solomon Benjamin J.,Maki Robert G.,Bang Yung-Jue,Kim Dong-Wan,Christensen James,Tan Weiwei,Wilner Keith D.,Salgia Ravi,Iafrate A. John

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. MET as a target for treatment of chest tumors;Cipriani;Lung Cancer,2009

2. Clinical implications of MET gene copy number in lung cancer;Toschi;Future Oncol,2010

3. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib;Bean;Proc Natl Acad Sci USA,2007

4. MET amplification leads to gefitinib resistance in lung cancer activating ERBB3 signaling;Engelman;Science,2007

5. Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer;Okuda;Cancer Sci,2008

Cited by 392 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil;Cancers;2024-09-03

2. Novel therapeutic strategies for rare mutations in non-small cell lung cancer;Scientific Reports;2024-05-05

3. Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies;Drug Delivery and Translational Research;2024-04-10

4. Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET;Journal of Experimental & Clinical Cancer Research;2024-04-03

5. Next-Generation Sequencing in Lung Cancers—A Single-Center Experience in Taiwan;Medicina;2024-01-29